London-based Thena Capital has secured £45m for its inaugural fund targeting digital healthcare and medical device startups. The firm will back UK companies working in these sectors, providing capital and support to help them expand into the US market. This represents the firm's first dedicated healthcare investment vehicle.

The fund focuses specifically on digital healthcare innovation and medical devices, sectors that have seen significant investor interest following pandemic-driven acceleration in health technology adoption. Thena Capital's strategy involves identifying promising UK-based companies and supporting their transatlantic expansion, addressing a common challenge faced by European healthtech ventures seeking US market entry.

Notably, Thena Capital operates as an all-female GP firm, distinguishing itself in an industry where women remain underrepresented in leadership roles. The £45m fund size positions it as a meaningful player in the UK healthcare investment landscape, particularly for early-stage companies requiring capital to scale internationally.

The launch reflects growing investor confidence in UK healthcare technology and the increasing importance of bridging European innovation with US commercial opportunities. This approach addresses a critical gap in the market for specialized healthcare-focused capital with international expansion expertise.